American journal of phytomedicine and clinical therapeutics · 2014 · 20 citations · 7 references
PharmacyMedicinal ChemistryPharmacologyBiochemical PharmacologyDrug DiscoveryStructure-activity RelationshipsAntioxidant DefenseMedicinal PlantsStructure-activity Relationship AnalysisAntimalarial AgentsAntimalarial Drug DevelopmentAntioxidant Activity AssaysAntioxidant MetabolitesAntioxidant Natural ProductsNitric OxideNitric Oxide ScavengingSynthetic Antioxidants
A new molecule of 2-[3, 4 di hydroxy phenyl] 3, 5, 14-trihydroxy 13-oxo 2H-chromeno [3 1 4 1 :5, 6] pyrano [2, 3-h] 4H-chromene 4-one was synthesized and screened. This new compound was synthesized by incorporating 4-chloro-3-formyl coumarin group with quercetin compound. In the present study the antioxidant and antimalarial activities of new 2-[3, 4 di hydroxy phenyl] 3, 5, 14-trihydroxy 13-oxo 2H-chromeno [3 1 4 1 :5, 6] pyrano [2, 3-h] 4H-chromene 4-one molecule was studied. The Antioxidant activity was performed by 1, 1-diphenyl-2-picryl hydrazyl free radical scavenging activity, phosphomolybdenum method, reducing power method and scavenging of nitric oxide methods and the calculated IC 50 values for new molecule and reference standard gallic acid were 1.77µg/ml, 0.13µg/ml respectively for DPPH method and 1.93µg/ml, 0.28µg/ml respectively for nitric oxide method. The antimalarial activity was performed by SYBR green I assay and by inhibition of β-hematin formation. These findings reveal that the new molecule 2-[3, 4 di hydroxy phenyl] 3, 5, 14-trihydroxy 13-oxo 2H-chromeno [3 1 4 1 :5, 6] pyrano [2, 3-h] 4H-chromene 4-one has good antimalarial and antioxidant activities and could be an alternate candidate for the development of new biologically active compounds.
7
G. Deepa, Hans‐Peter Fuehrer, Peter Starzengrüber et al. · Parasitology Research · 2012 · 92 citations